• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preparation of a novel floating ring capsule-type dosage form for stomach specific delivery.制备一种新型的漂浮环胶囊型剂型,用于胃部定位释放。
Saudi Pharm J. 2011 Apr;19(2):85-93. doi: 10.1016/j.jsps.2011.01.004. Epub 2011 Jan 18.
2
Formulation, development, and evaluation of floating pulsatile drug delivery system of atenolol.阿替洛尔胃内漂浮脉冲式给药系统的制剂、开发与评价
PDA J Pharm Sci Technol. 2013 May-Jun;67(3):214-28. doi: 10.5731/pdajpst.2013.00916.
3
Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.诺氟沙星缓释漂浮药物递送系统的研制:体外与体内评价
PDA J Pharm Sci Technol. 2011 May-Jun;65(3):198-206. doi: 10.5731/pdajpst.2011.00685.
4
Development and evaluation of a monolithic floating drug delivery system for acyclovir.阿昔洛韦整体式漂浮药物递送系统的研发与评价
Chem Pharm Bull (Tokyo). 2012;60(2):172-7. doi: 10.1248/cpb.60.172.
5
Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design.采用析因设计研究羟丙甲纤维素和卡波姆对胃漂浮给药系统释放度和漂浮性能的影响。
Int J Pharm. 2003 Mar 6;253(1-2):13-22. doi: 10.1016/s0378-5173(02)00642-7.
6
Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug.以盐酸雷尼替丁为模型药物的羟丙基甲基纤维素和聚环氧乙烷胃漂浮片的制剂与体外评价
J Young Pharm. 2012 Oct;4(4):201-8. doi: 10.4103/0975-1483.104363.
7
Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.盐酸美贝维林胃滞留漂浮型骨架片和漂浮筏系统的处方、释放特性及生物利用度研究
Drug Des Devel Ther. 2017 Apr 3;11:1081-1093. doi: 10.2147/DDDT.S131936. eCollection 2017.
8
Metronidazole Based Floating Bioadhesive Drug Delivery System for Potential Eradication of : Preparation and In Vitro Characterization.基于甲硝唑的漂浮型生物黏附药物递送系统用于潜在根除:制备与体外表征
Polymers (Basel). 2022 Jan 27;14(3):519. doi: 10.3390/polym14030519.
9
Formulation and evaluation of different floating tablets containing metronidazole to target stomach.含甲硝唑的不同胃靶向漂浮片的制剂与评价
Curr Drug Deliv. 2015;12(4):425-43. doi: 10.2174/156720181204150729125655.
10
Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.制剂参数对阿司匹林胃漂浮双层片释药和漂浮性能的影响。
Acta Pharm. 2011 Sep 1;61(3):303-12. doi: 10.2478/v10007-011-0028-0.

引用本文的文献

1
Pharmacological evaluation of levofloxacin residue depletion and hemato-biochemical alterations in broiler chickens using a validated HPLC method.使用经过验证的高效液相色谱法对肉鸡中左氧氟沙星残留消除及血液生化改变进行药理学评估。
Sci Rep. 2025 Sep 12;15(1):32496. doi: 10.1038/s41598-025-17575-0.
2
Preparation and In Vitro Evaluation of Levofloxacin-Loaded Floating Tables Using Various Rate-Controlling Agents.使用各种速率控制剂制备载有左氧氟沙星的漂浮片并进行体外评价。
ACS Omega. 2023 Nov 1;8(45):42659-42666. doi: 10.1021/acsomega.3c05419. eCollection 2023 Nov 14.
3
Robust antibacterial activity of functionalized carbon nanotube- levofloxacine conjugate based on in vitro and in vivo studies.基于体外和体内研究的功能化碳纳米管-左氧氟沙星缀合物的强大抗菌活性。
Sci Rep. 2022 Jun 16;12(1):10064. doi: 10.1038/s41598-022-14206-w.
4
Sustainable waste management and recycling of Zn-Al layered double hydroxide after adsorption of levofloxacin as a safe anti-inflammatory nanomaterial.左氧氟沙星吸附后作为安全抗炎纳米材料的锌铝层状双氢氧化物的可持续废物管理与回收利用。
RSC Adv. 2020 Jul 23;10(46):27633-27651. doi: 10.1039/d0ra04898d. eCollection 2020 Jul 21.
5
In pursuit of new anti-malarial candidates: novel synthesized and characterized pyrano-benzodioxepin analogues attenuated replication in malaria-infected mice.寻找新型抗疟候选药物:新型合成并表征的吡喃并苯并二氧六环类似物可减弱疟原虫在感染疟疾小鼠体内的复制。
Heliyon. 2021 Dec 2;7(12):e08517. doi: 10.1016/j.heliyon.2021.e08517. eCollection 2021 Dec.
6
Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.用于根除幽门螺杆菌的胃滞留型左氧氟沙星漂浮微丸胶囊系统的设计与评价
Saudi Pharm J. 2014 Dec;22(6):570-9. doi: 10.1016/j.jsps.2014.02.009. Epub 2014 Mar 6.

本文引用的文献

1
The effect of density on the gastric emptying of single- and multiple-unit dosage forms.密度对单剂量和多剂量剂型胃排空的影响。
Pharm Res. 1986 Aug;3(4):208-13. doi: 10.1023/A:1016334629169.
2
Formulation and optimization of Zidovudine niosomes.齐多夫定非离子囊泡的制备与优化。
AAPS PharmSciTech. 2010 Sep;11(3):1119-27. doi: 10.1208/s12249-010-9480-2. Epub 2010 Jul 16.
3
Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.混合物实验设计在含卡波姆和羟丙甲纤维素的基质片剂的配方和优化中的应用。
Arch Pharm Res. 2009 Dec;32(12):1767-74. doi: 10.1007/s12272-009-2215-9. Epub 2010 Feb 17.
4
The capsule drug device: novel approach for drug delivery to the eye.胶囊药物装置:眼部给药的新方法。
Vision Res. 2010 Mar 31;50(7):680-5. doi: 10.1016/j.visres.2009.10.013. Epub 2009 Oct 23.
5
Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.用于潜在肌肉注射的载酮咯酸氨丁三醇白蛋白微球的制备与评价
AAPS PharmSciTech. 2007 Feb 23;8(1):14. doi: 10.1208/pt0801014.
6
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.基于左氧氟沙星的三联疗法用于幽门螺杆菌根除的一线治疗。
Am J Gastroenterol. 2006 Sep;101(9):1985-90. doi: 10.1111/j.1572-0241.2006.00716.x.
7
Treatment of Helicobacter pylori infection.幽门螺杆菌感染的治疗。
Helicobacter. 2006 Oct;11 Suppl 1:36-9. doi: 10.1111/j.1478-405X.2006.00428.x.
8
Characterization of 5-fluorouracil microspheres for colonic delivery.用于结肠给药的5-氟尿嘧啶微球的特性研究
AAPS PharmSciTech. 2006 May 26;7(2):E47. doi: 10.1208/pt070247.
9
Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage.在处方前研究阶段研究不同纤维素衍生物对药物释放机制的影响。
J Control Release. 2004 Feb 20;95(1):101-8. doi: 10.1016/j.jconrel.2003.11.009.
10
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.

制备一种新型的漂浮环胶囊型剂型,用于胃部定位释放。

Preparation of a novel floating ring capsule-type dosage form for stomach specific delivery.

机构信息

Department of Pharmaceutical Technology, Y.B. Chavan College of Pharmacy, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India.

出版信息

Saudi Pharm J. 2011 Apr;19(2):85-93. doi: 10.1016/j.jsps.2011.01.004. Epub 2011 Jan 18.

DOI:10.1016/j.jsps.2011.01.004
PMID:23960746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3745050/
Abstract

Study objectives were to develop a unique floating ring capsule dosage form which combines gastric soluble and insoluble portions, and to evaluate its suitability for stomach specific drug delivery. New floating ring capsules were developed using different polymers and were compared for various parameters. The formulation with HPMC and sodium CMC has better floating properties. The effects of polymers concentration on drug release were studies by in vitro release studies. The interaction studies of combined drug with polymers were determined using FT-IR spectroscopy. The entrapped air within the gel barrier and lower densities of HPMC and sodium CMC resulted in better floating behavior. Steady slow gel formations showed prolonged drug release. The in vitro release rates were generally found to be faster with low concentration of carbopol showing release within 2 h, while formulations containing high amount of HPMC showed release in 8 h. In particular, the higher concentration of HPMC formulation shows the best drug release performance. A very low change in peak shift was observed only with sodium alginate formulations. Further, FT-IR measurements confirmed the absence of any chemical interactions. Results indicate that new floating ring capsule is a promise dosage form for stomach specific delivery.

摘要

研究目的是开发一种独特的漂浮环胶囊剂型,将胃溶性和不溶性部分结合在一起,并评估其用于胃特定药物输送的适用性。使用不同的聚合物开发了新的漂浮环胶囊,并对其各种参数进行了比较。HPMC 和羧甲基纤维素钠的配方具有更好的漂浮性能。通过体外释放研究研究了聚合物浓度对药物释放的影响。使用傅里叶变换红外光谱法确定了组合药物与聚合物的相互作用研究。凝胶屏障内夹带的空气和 HPMC 和羧甲基纤维素钠的较低密度导致更好的漂浮行为。稳定的缓慢凝胶形成显示出延长的药物释放。通常发现低浓度的卡波姆具有更快的体外释放率,在 2 小时内释放,而含有高浓度 HPMC 的制剂则在 8 小时内释放。特别是,HPMC 浓度较高的制剂显示出最佳的药物释放性能。仅用海藻酸钠制剂观察到峰位移的变化非常小。此外,傅里叶变换红外测量证实不存在任何化学相互作用。结果表明,新型漂浮环胶囊是一种有前途的胃特定给药剂型。